Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
318
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0602
Pancreatic Polypepti
APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY
Ala-Pro-Leu-Glu-Pro-Glu-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Glu-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr
NA
36
Linear
NA
human
[H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0131 ml/g
Direct iodination
7617725
b3pdb_0603
Pancreatic Polypepti
APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY
Ala-Pro-Leu-Glu-Pro-Glu-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Glu-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr
NA
36
Linear
NA
human
[H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
% injected dose
0.065 %/g
Direct iodination
7617725
b3pdb_0613
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0002 mL/(g x min)
Direct iodination
18006117
b3pdb_0614
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.00979 ml/g
Direct iodination
18006117
b3pdb_0615
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
half life, serum
9.46 min
Direct iodination
18006117
b3pdb_0616
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
CD (capillary/serum)
0.0012 ml/g
Direct iodination
17950952
b3pdb_0617
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
CD (brain/serum)
0.00598 ml/g
Direct iodination
17950952
b3pdb_0618
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01422 ml/g
Direct iodination
17950952
b3pdb_0619
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00011 mL/(g x min)
Direct iodination
17950952
b3pdb_0625
Epidermal growth fac
NSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELR
Asn-Ser-Asp-Ser-Glu-Cys-Pro-Leu-Ser-His-Asp-Gly-Tyr-Cys-Leu-His-Asp-Gly-Val-Cys-Met-Tyr-Ile-Glu-Ala-Leu-Asp-Lys-Tyr-Ala-Cys-Asn-Cys-Val-Val-Gly-Tyr-Ile-Gly-Glu-Arg-Cys-Gln-Tyr-Arg-Asp-Leu-Lys-Trp-Trp-Glu-Leu-Arg
NA
NA
Cys6-Cys20, Cys14-Cys31, Cys33-Cys42
53
Linear
NA
human,synthetic
[H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.00202 mL/(g x min)
Direct iodination
10499427
b3pdb_0631
[Met(O)67]-(cocaine
VPIYEKKYGQVPM(O)CDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL
Val-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met(O)-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu
NA
NA
Cys14-Cys32 Cys20-Cys40 Cys34-Cys47
48
Linear
NA
rat
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00051 mL/(g x min)
Direct iodination
10567018
b3pdb_0637
Mahogany (1377-1428)
GLGGIPPPGQSGLAVASALVDISQQMPIVYKEKSGAVRNRKQQPPAQPGTCI
Gly-Leu-Gly-Gly-Ile-Pro-Pro-Pro-Gly-Gln-Ser-Gly-Leu-Ala-Val-Ala-Ser-Ala-Leu-Val-Asp-Ile-Ser-Gln-Gln-Met-Pro-Ile-Val-Tyr-Lys-Glu-Lys-Ser-Gly-Ala-Val-Arg-Asn-Arg-Lys-Gln-Gln-Pro-Pro-Ala-Gln-Pro-Gly-Thr-Cys-Ile
NA
52
Linear
NA
human
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.00055 mL/(g x min)
Direct iodination
10900242
b3pdb_0647
Urocortin II
VILSLDVPIGLLRILLEQARYKAARNQAATNAQILAHV
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val
NA
NA
NA
38
Linear
NA
rat
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.0005905 mL/(g x min)
Direct iodination
12065889
b3pdb_0662
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0007944 mL/(g x min)
Direct iodination
30293893
b3pdb_0663
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.001775 ml/g
Direct iodination
30293893
b3pdb_0672
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00049 mL/(g x min)
Direct iodination
12750431
b3pdb_0673
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.012 ml/g
Direct iodination
12750431
b3pdb_0674
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
% injected dose
0.176 %/g
Direct iodination
12750431
b3pdb_0693
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
-0.000023 mL/(g x min)
Direct iodination
20347901
b3pdb_0694
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01959 ml/g
Direct iodination
20347901
b3pdb_0709
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
2
Linear
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
NA
NA
NA
NA
Unidirectional influx rate constant
0.00018 mL/(g x min)
Direct iodination
11033091
b3pdb_0710
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.000179 mL/(g x min)
Direct iodination
8498494
b3pdb_0711
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.0239 ml/g
Direct iodination
8498494
b3pdb_0712
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
half life, brain
25.6 min
Direct iodination
8498494
b3pdb_0713
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Brain elimination rate constant
0.0118 min-1
Direct iodination
8498494
b3pdb_0725
DALDA
YrFK
Tyr-(D)Arg-Phe-Lys
NA
NA
NA
4
Linear
NA
human
O=C(O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)CCCCN
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Peak response
0.84 µL/(g x min)
H3/C14
8048500
b3pdb_0733
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.0004 mL/(g x min)
Direct iodination
20347901
b3pdb_0734
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.03453 ml/g
Direct iodination
20347901
b3pdb_0741
TAPA
YrF-βA
Tyr-(D)Arg-Phe-βAla
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CCNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.000265 mL/(g x min)
Direct iodination
12603838
b3pdb_0742
TAPA
YrF-βA
Tyr-(D)Arg-Phe-βAla
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CCNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Initial disrobution volume
0.00869 ml/g
Direct iodination
12603838
b3pdb_0750
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00018 mL/(g x min)
Direct iodination
20347901
b3pdb_0751
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01859 ml/g
Direct iodination
20347901
b3pdb_0758
TAPP
YaFF-NH2
Tyr-(D)Ala-Phe-Phe-NH2
NA
NA
NA
4
Linear
NA
bovine
O=C(N)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccccc3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00112 mL/(g x min)
Direct iodination
20347901
b3pdb_0759
TAPP
YaFF-NH2
Tyr-(D)Ala-Phe-Phe-NH2
NA
NA
NA
4
Linear
NA
bovine
O=C(N)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccccc3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.03176 ml/g
Direct iodination
20347901
b3pdb_0762
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00024 mL/(g x min)
Direct iodination
20347901
b3pdb_0763
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01894 ml/g
Direct iodination
20347901
b3pdb_0767
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.00218 mL/(g x min)
Direct iodination
20347901
b3pdb_0768
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Initial disrobution volume
0.02148 ml/g
Direct iodination
20347901
b3pdb_0769
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01398 ml/g
Direct iodination
26465925
b3pdb_0770
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00063 mL/(g x min)
Direct iodination
26465925
b3pdb_0771
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00019 mL/(g x min)
Direct iodination
24164260
b3pdb_0772
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00035 mL/(g x min)
Direct iodination
8041755
b3pdb_0775
mouse Obestatin
FNAPFDVGIKLSGAQYQQHGRAL-NH2
Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg- Ala-Leu-NH2
NA
NA
NA
23
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00186 mL/(g x min)
Direct iodination
16476508
b3pdb_0776
mouse Obestatin
FNAPFDVGIKLSGAQYQQHGRAL-NH2
Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg- Ala-Leu-NH2
NA
NA
NA
23
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01853 ml/g
Direct iodination
16476508
b3pdb_0781
P41
(Me2)Y-rFK-NH2
(Me2)Tyr-(D)Arg-Phe-Lys-NH2
NA
NA
NA
4
Linear
NA
O=C(N)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c(cc(O)cc1C)C)CCCNC(=[N@H])N)Cc2ccccc2)CCCCN
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant,initial
0.00944 ml/(g x min)
Direct iodination
23102273
b3pdb_0782
P41
(Me2)Y-rFK-NH2
(Me2)Tyr-(D)Arg-Phe-Lys-NH2
NA
NA
NA
4
Linear
NA
O=C(N)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c(cc(O)cc1C)C)CCCNC(=[N@H])N)Cc2ccccc2)CCCCN
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01925 ml/g
Direct iodination
23102273
b3pdb_0783
P41
(Me2)Y-rFK-NH2
(Me2)Tyr-(D)Arg-Phe-Lys-NH2
NA
NA
NA
4
Linear
NA
O=C(N)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c(cc(O)cc1C)C)CCCNC(=[N@H])N)Cc2ccccc2)CCCCN
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0003681 mL/(g x min)
Direct iodination
_
b3pdb_0787
P42
(Me2)Y-rF-Nle-NH2
(Me2)Tyr-(D)Arg-Phe-Nle-NH2
NA
NA
NA
4
Linear
NA
mouse
O=C(N)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c(cc(O)cc1C)C)CCCNC(=[N@H])N)Cc2ccccc2)CCCCC
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant,initial
0.00848 ml/(g x min)
Direct iodination
23102273
b3pdb_0788
P42
(Me2)Y-rF-Nle-NH2
(Me2)Tyr-(D)Arg-Phe-Nle-NH2
NA
NA
NA
4
Linear
NA
mouse
O=C(N)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c(cc(O)cc1C)C)CCCNC(=[N@H])N)Cc2ccccc2)CCCCC
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02743 ml/g
Direct iodination
23102273
b3pdb_0789
P42
(Me2)Y-rF-Nle-NH2
(Me2)Tyr-(D)Arg-Phe-Nle-NH2
NA
NA
NA
4
Linear
NA
mouse
O=C(N)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c(cc(O)cc1C)C)CCCNC(=[N@H])N)Cc2ccccc2)CCCCC
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0002485 mL/(g x min)
Direct iodination
_
previous
1
2
3
4
5
6
7
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD
